Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Home
Faculty
Departments
Grants
Publications
Prizes
Search by expertise, name or affiliation
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
SONAR Committees and Investigators
Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
407
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Albumins
10%
Albuminuria
6%
Anemia
4%
Atrasentan
100%
Body Surface Area
6%
Chronic Kidney Failure
10%
Chronic Renal Insufficiency
54%
Creatinine
14%
Dialysis
5%
Double-Blind Method
5%
Endothelin A Receptor Antagonists
8%
Endothelin Receptor Antagonists
15%
Glomerular Filtration Rate
11%
Heart Failure
4%
Intention
5%
Kidney
31%
Kidney Transplantation
5%
Placebos
40%
Population
2%
Psychological Inhibition
4%
Psychology Retention
13%
Randomized Controlled Trials
40%
Renal Insufficiency
5%
Research Personnel
4%
Safety
6%
Serum
2%
Sodium
4%
Therapeutics
4%
Type 2 Diabetes Mellitus
44%
Urine
8%